“genentech” Archives

in
Entry Author Date Location
Liver Damage, Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials 12/27/16 Seattle
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
Despite FDA Delay, Advocates Hopeful for New Genentech MS Drug 12/21/16 San Francisco
Ophthotech Eye Drug Fails Badly in Pivotal Test, Shares Crumble 12/12/16 New York
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data 11/01/16 National
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders 10/20/16 San Francisco
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
New Rockefeller Prez Takes Stock of “Wildly Underdeveloped” NY Bio Scene 09/27/16 New York
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
In Immuno-Oncology’s Latest Win, FDA OK’s Genentech Drug 05/18/16 San Francisco
Rockefeller Taps Yale Genetics Chief Richard Lifton As New President 05/06/16 New York
$220M Richer, Human Longevity Ups Ante In Genomics Business Race 04/04/16 San Diego
Nimbus’s LLC Origins Pay off As Gilead Shells Out $400M For Liver Drug 04/04/16 Boston
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors 03/30/16 New York
West Coast Bio Roundup: Gilead Onco Woes, Adaptive Expansion & More 03/18/16 San Diego
Syndax Cuts Price But Bags $53M in Second IPO Try 03/02/16 Boston
On Comeback Trail, Exelixis Reels In $200M Deal For Cancer Drug 02/29/16 San Francisco
New York City: En Route to a Bio Cluster 02/29/16 New York
East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More 02/05/16 Boston
Rockefeller’s Tessier-Lavigne Heads Back to the Bay to Run Stanford 02/04/16 New York
Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug 01/27/16 Boston
West Coast Bio Roundup: Shkreli Cuffed, KaloBios Halted & More 12/17/15 National
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
With Startup, Bio Pioneer Tom Maniatis Looks to Spark NY Scene Again 12/10/15 New York
Page 2 of 19 « previous page · next page »